ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $27,238,000 | -36.1% | 10,317,698 | -12.8% | 0.65% | -41.2% |
| Q1 2021 | $42,605,000 | +35.6% | 11,834,667 | -5.1% | 1.10% | +15.4% |
| Q4 2020 | $31,415,000 | +0.7% | 12,466,248 | +0.7% | 0.96% | -14.6% |
| Q3 2020 | $31,211,000 | -24.6% | 12,385,586 | -1.9% | 1.12% | -39.1% |
| Q2 2020 | $41,393,000 | +31.4% | 12,619,730 | -1.8% | 1.84% | -9.3% |
| Q1 2020 | $31,500,000 | -47.6% | 12,857,035 | +1.0% | 2.03% | -5.0% |
| Q4 2019 | $60,106,000 | +8.2% | 12,734,235 | -1.9% | 2.13% | -4.6% |
| Q3 2019 | $55,568,000 | +3.2% | 12,983,146 | +40.5% | 2.23% | +9.0% |
| Q2 2019 | $53,864,000 | +51.4% | 9,239,150 | 0.0% | 2.05% | +45.4% |
| Q1 2019 | $35,570,000 | +114.1% | 9,239,150 | -0.3% | 1.41% | +86.9% |
| Q4 2018 | $16,617,000 | +7.8% | 9,264,700 | +92.3% | 0.75% | +51.4% |
| Q3 2018 | $15,416,000 | +3.8% | 4,817,546 | -2.0% | 0.50% | -10.1% |
| Q2 2018 | $14,848,000 | -24.8% | 4,916,671 | -2.4% | 0.55% | -32.7% |
| Q1 2018 | $19,749,000 | -6.2% | 5,037,946 | -0.9% | 0.82% | -8.1% |
| Q4 2017 | $21,049,000 | -29.4% | 5,084,246 | +4.6% | 0.90% | -30.1% |
| Q3 2017 | $29,830,000 | -2.7% | 4,858,356 | -1.4% | 1.28% | +3.1% |
| Q2 2017 | $30,643,000 | -1.9% | 4,926,456 | +0.0% | 1.24% | -9.5% |
| Q1 2017 | $31,227,000 | +19.1% | 4,925,321 | +0.5% | 1.37% | +19.5% |
| Q4 2016 | $26,219,000 | -7.0% | 4,900,721 | -2.1% | 1.15% | -0.3% |
| Q3 2016 | $28,184,000 | +2.6% | 5,005,921 | 0.0% | 1.15% | -6.1% |
| Q2 2016 | $27,483,000 | -32.3% | 5,005,921 | -8.5% | 1.23% | -21.3% |
| Q1 2016 | $40,577,000 | +1.9% | 5,468,521 | +14.1% | 1.56% | +46.5% |
| Q4 2015 | $39,838,000 | +11.8% | 4,793,896 | +21.3% | 1.07% | +4.2% |
| Q3 2015 | $35,622,000 | -14.6% | 3,953,597 | +13.7% | 1.02% | -29.2% |
| Q2 2015 | $41,731,000 | +29.2% | 3,477,547 | +15.9% | 1.44% | +28.0% |
| Q1 2015 | $32,310,000 | – | 3,000,000 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |